Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v5-EN
Language English English
Date Updated 2019-06-19 2019-06-12
Drug Identification Number 02353849 02353849
Brand name MYLAN-LANSOPRAZOLE MYLAN-LANSOPRAZOLE
Common or Proper name LANSOPRAZOLE LANSOPRAZOLE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients LANSOPRAZOLE LANSOPRAZOLE
Strength(s) 30MG 30MG
Dosage form(s) CAPSULE (DELAYED RELEASE) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BT 100 BT
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-06-11 2019-06-11
Actual start date
Estimated end date Unknown Unknown
Actual end date 2019-06-18
Shortage status Resolved Actual shortage
Company comments
Health Canada comments